Surface Activation and Pretreatments for Biocompatible Metals and Alloys Used in Biomedical Applications

<table class="fixed-width table-group" id="tab5"><tr><td><table class="table"><colgroup><col style="width:6.85em"/><col style="width:7.67em"/><col style="width:6.39em"/></colgroup><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Aspartic acid addition (mM)</td><td class="align_center"><svg height="11.6836pt" id="M37" style="vertical-align:-3.29562pt" version="1.1" viewbox="-0.0498162 -8.38798 23.5922 11.6836" width="23.5922pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M517 162C503 123 484 88 467 68C445 42 417 34 341 34C291 34 256 34 237 47C219 59 213 81 213 128V317H308C395 317 402 311 415 240H444V431H415C403 364 398 356 307 356H213V584C213 613 215 616 246 616H322C394 616 421 609 435 587C448 566 458 544 467 502L496 506C493 557 488 625 488 650H42V622C120 616 128 612 128 523V125C128 43 120 35 29 28V0H511C520 31 540 125 546 158L517 162Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,7.384,3.132)"><path d="M396 114C349 71 317 59 274 59C216 59 123 104 123 241C123 342 180 400 246 400C283 400 317 386 348 359C355 352 361 348 366 348C378 348 401 371 402 394C402 405 398 413 385 424C369 437 337 451 294 451H293C254 451 193 434 141 394C73 342 39 277 39 198C39 90 114 -12 243 -12C303 -12 371 31 415 90L396 114Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,11.315,3.132)"><path d="M262 451C169 451 38 375 38 210C38 98 121 -12 261 -12C360 -12 481 64 481 227C481 351 386 451 262 451ZM249 414C337 414 385 320 385 204C385 70 333 25 272 25C189 25 134 117 134 241C134 355 189 414 249 414Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,15.928,3.132)"><path d="M185 344V453C137 433 92 421 41 413V386C100 378 104 375 104 310V106C104 41 97 35 33 30V0H268V30C190 35 185 41 185 107V283C206 340 240 371 267 371C282 371 296 364 310 351C316 344 325 343 336 348C357 357 369 378 369 399C369 424 345 451 310 451C262 451 219 397 187 344H185Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,19.45,3.132)"><path d="M185 344V453C137 433 92 421 41 413V386C100 378 104 375 104 310V106C104 41 97 35 33 30V0H268V30C190 35 185 41 185 107V283C206 340 240 371 267 371C282 371 296 364 310 351C316 344 325 343 336 348C357 357 369 378 369 399C369 424 345 451 310 451C262 451 219 397 187 344H185Z"></path></g></svg> (V vs SCE)</td><td class="align_center"><svg height="11.6836pt" id="M38" style="vertical-align:-3.29562pt" version="1.1" viewbox="-0.0498162 -8.38798 20.6301 11.6836" width="20.6301pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M303 0V28C221 34 213 39 213 125V525C213 610 221 616 303 622V650H38V622C120 616 128 610 128 525V125C128 40 120 34 38 28V0H303Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,4.433,3.132)"><path d="M396 114C349 71 317 59 274 59C216 59 123 104 123 241C123 342 180 400 246 400C283 400 317 386 348 359C355 352 361 348 366 348C378 348 401 371 402 394C402 405 398 413 385 424C369 437 337 451 294 451H293C254 451 193 434 141 394C73 342 39 277 39 198C39 90 114 -12 243 -12C303 -12 371 31 415 90L396 114Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.364,3.132)"><path d="M262 451C169 451 38 375 38 210C38 98 121 -12 261 -12C360 -12 481 64 481 227C481 351 386 451 262 451ZM249 414C337 414 385 320 385 204C385 70 333 25 272 25C189 25 134 117 134 241C134 355 189 414 249 414Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,12.978,3.132)"><path d="M185 344V453C137 433 92 421 41 413V386C100 378 104 375 104 310V106C104 41 97 35 33 30V0H268V30C190 35 185 41 185 107V283C206 340 240 371 267 371C282 371 296 364 310 351C316 344 325 343 336 348C357 357 369 378 369 399C369 424 345 451 310 451C262 451 219 397 187 344H185Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,16.499,3.132)"><path d="M185 344V453C137 433 92 421 41 413V386C100 378 104 375 104 310V106C104 41 97 35 33 30V0H268V30C190 35 185 41 185 107V283C206 340 240 371 267 371C282 371 296 364 310 351C316 344 325 343 336 348C357 357 369 378 369 399C369 424 345 451 310 451C262 451 219 397 187 344H185Z"></path></g></svg> (A/cm<sup>2</sup>)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">0</td><td class="align_center">-0.480</td><td class="align_center">1.0 × 10<sup>−8</sup></td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left">4</td><td class="align_center">-0.465</td><td class="align_center">1.1 × 10<sup>−8</sup></td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left">8</td><td class="align_center">-0.299</td><td class="align_center">2.5 × 10<sup>−8</sup></td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left">10</td><td class="align_center">-0.310</td><td class="align_center">7.9 × 10<sup>−9</sup></td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Potentiodynamic polarization values for acid pretreatment of CoCrMo alloys (Courtesy of I. Coskun and T.D. Golden, 2018).</div>

International Journal of Biomaterials

tab5

Table 5

Table 5: Surface Activation and Pretreatments for Biocompatible Metals and Alloys Used in Biomedical Applications 